The Department of Health and Human Services has entered strategic partnerships with a Roche Group subsidiary and The Medicines Co. to develop antibiotics against multi-drug resistant infections.
HHS’ office of the assistant secretary for preparedness and response forged the partnerships with the two companies through other transaction authority under the Pandemic and All Hazards Preparedness Act of 2006, HHS said Wednesday.